These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 20042305)

  • 1. [Valuation of innovation: a new challenge for the structures of care, an opportunity for everybody...].
    Sezeur A
    J Mal Vasc; 2010 Feb; 35(1):1-3. PubMed ID: 20042305
    [No Abstract]   [Full Text] [Related]  

  • 2. [Valuation of innovation: a new challenge for the structures of care, an opportunity for everybody...].
    Sezeur A
    J Chir (Paris); 2009 Aug; 146(4):333-5. PubMed ID: 19762023
    [No Abstract]   [Full Text] [Related]  

  • 3. What's holding us back? Understanding barriers to innovation in academic neurosurgery.
    Leuthardt EC
    Surg Neurol; 2006 Oct; 66(4):347-9; discussion 349. PubMed ID: 17015102
    [No Abstract]   [Full Text] [Related]  

  • 4. [Self-interest can be of benefit for everyone and save medical research].
    Fändriks L; Edén S
    Lakartidningen; 2001 Jun; 98(26-27):3146-9. PubMed ID: 11478213
    [No Abstract]   [Full Text] [Related]  

  • 5. [Medical innovation. Patents and confidentiality].
    Laccourreye O; Sezeur A; Cauchois R; Rodhain C
    Ann Otolaryngol Chir Cervicofac; 1993; 110(3):173-6. PubMed ID: 8239339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Protection of medical innovations].
    Sezeur A; Tarragano O
    Gastroenterol Clin Biol; 1987 May; 11(5):418-20. PubMed ID: 3609636
    [No Abstract]   [Full Text] [Related]  

  • 7. [Industry and pharmaceutical research in Italy. How to make up for lost time].
    Mortari U
    Recenti Prog Med; 2006 Nov; 97(11):634-9. PubMed ID: 17252720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ownership of knowledge--the role of patents in pharmaceutical R&D.
    Correa CM
    Bull World Health Organ; 2004 Oct; 82(10):784-7; discussion 787-90. PubMed ID: 15643801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [From intellectual property to commercial property].
    Cappelaere P
    Bull Cancer; 2005 Apr; 92(4):297-8. PubMed ID: 15888384
    [No Abstract]   [Full Text] [Related]  

  • 10. [Biomedical research: cost-benefit analysis].
    Huygelen C
    Verh K Acad Geneeskd Belg; 1992; 54(6):599-610. PubMed ID: 1296405
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethics and industry-sponsored research.
    Koehler B
    CMAJ; 2002 Mar; 166(5):581; author reply 582. PubMed ID: 11898935
    [No Abstract]   [Full Text] [Related]  

  • 12. The 1992 biotechnology agenda: a message for candidates Bush and Clinton.
    Duzan SA
    Healthspan; 1992 Sep; 9(8):12-5. PubMed ID: 10122052
    [No Abstract]   [Full Text] [Related]  

  • 13. The changing environment for technological innovation in health care.
    Goodman CS; Gelijns AC
    Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patenting DNA and amino acid sequences--an Australian perspective.
    Keays D
    Health Law J; 1999; 7():69-90. PubMed ID: 11066370
    [No Abstract]   [Full Text] [Related]  

  • 15. Much ado about gene patents: the role of foreseeability.
    Gulliford MJ
    Seton Hall Law Rev; 2004; 34(2):711-45. PubMed ID: 15115032
    [No Abstract]   [Full Text] [Related]  

  • 16. Establishing novelty and relevant prior art.
    Murphy C
    Nat Rev Drug Discov; 2004 Jul; 3(7):545. PubMed ID: 15272495
    [No Abstract]   [Full Text] [Related]  

  • 17. Clearing a path through the patent thicket.
    Holman C
    Cell; 2006 May; 125(4):629-33. PubMed ID: 16713553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patent pending. The challenges of bringing an invention to market.
    Goldman PM
    Minn Med; 1999 Sep; 82(9):29-31. PubMed ID: 10510615
    [No Abstract]   [Full Text] [Related]  

  • 19. Gene patent policy: does issuing gene patents accord with the purposes of the U.S. patent system?
    Bradshaw J
    Willamette Law Rev; 2001; 37(4):637-60. PubMed ID: 12774776
    [No Abstract]   [Full Text] [Related]  

  • 20. The incorporation of new technologies into genetic services; the importance of government support.
    Holtzman NA
    Birth Defects Orig Artic Ser; 1992; 28(3):126-30. PubMed ID: 1489950
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.